Acer Therapeutics Inc (NASDAQ:ACER)

20.68
Delayed Data
As of Jun 22
 +1.43 / +7.43%
Today’s Change
5.70
Today|||52-Week Range
22.63
+49.31%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-678.2K-8.4M-4.2M-4.0M
 
 
 
 
 
Depreciation0.002.7K1.3K6.2K
 
 
 
 
Total Other Cash Flow48.3K285.9K282.6K252.4K
 
 
 
 
 
Funds From Operations-629.9K-8.1M-3.9M-3.7M
 
 
 
 
 
Funds From/For Other Operating Expenses303.1K-152.7K276.3K-497.8K
 
 
 
 
 
Net Cash Flow - Operating Activities-933.0K-7.9M-4.2M-3.2M
 
 
 
 
 
 
InvestingCapital Expenditures-----60.3K-9.8K
 
 
 
Fixed Asset Disposal0.00980.1K0.00--
 
 
Net Cash Flow Investing0.00977.6K-60.3K-9.8K
 
 
 
 
 
FinancingShort Term Borrowings-65.3K5.6M-5.5M0.00
 
 
 
 
Long Term Borrowings0.00-68.5K5.5M0.00
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale0.009.6M11.5M-38.7K
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.00----0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing-65.3K15.1M11.5M-38.8K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-998.3K8.2M7.2M-3.3M